Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 12/20 | 0.54 |
| ▸ | CTSL | P07711 | 10/20 | 0.50 |
| ▸ | CTSK | P43235 | 10/20 | 0.50 |
| ▸ | CTSS | P25774 | 8/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7450076 | 0.90 | CTSB (0.54) | CTSBCTSLCTSKCTSSKDM4E | |
| SCHEMBL6185994 | 0.90 | CTSB (0.54) | CTSBCTSLCTSKCTSSKDM4E | |
| SCHEMBL7515230 | 0.87 | CTSB (0.52) | CTSBCTSLCTSKCTSSKDM4E | |
| SCHEMBL7486512 | 0.85 | CTSB (0.50) | CTSBCTSLCTSKCTSS | |
| SCHEMBL7494273 | 0.84 | CTSB (0.50) | CTSBCTSLCTSKCTSSKDM4E | |
| SCHEMBL7490691 | 0.83 | CTSB (0.51) | CTSBCTSLCTSKCTSSALDH1A1 | |
| SCHEMBL6181560 | 0.83 | CTSB (0.68) | CTSBCTSLCTSKCTSSKDM4E | |
| SCHEMBL7540238 | 0.83 | CTSK (0.58) | CTSBCTSLCTSKCTSS | |
| SCHEMBL7483503 | 0.83 | CTSB (0.50) | CTSBCTSLCTSKCTSSCAPN1 | |
| SCHEMBL7506517 | 0.82 | NPC1 (0.51) | CTSBCTSLCTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1161415-A2 | N-CYANOMETHYLAMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2001-12-12 | — | — | EP | disclosed |
| WO-2000055126-A2 | N-CYANOMETHYLAMIDES AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | disclosed |